Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Therapeutics - Autoimmune disease
SciBX 2(24); doi:10.1038/scibx.2009.966
Published online June 18 2009
Extra navigation
Prostaglandin E2 (PGE2) receptor EP4 subtype (prostanoid EP4 receptor) (PTGER4)
A study in cell culture and in mice suggests that antagonizing PTGER4 could be useful for treating MS. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
